SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-001232
Filing Date
2023-05-15
Accepted
2023-05-15 16:33:12
Documents
58
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q snpx-20230331x10q.htm   iXBRL 10-Q 1140733
2 EX-3.2 snpx-20230331xex3d2.htm EX-3.2 20212
3 EX-10.1 snpx-20230331xex10d1.htm EX-10.1 14478
4 EX-10.2 snpx-20230331xex10d2.htm EX-10.2 21164
5 EX-31.1 snpx-20230331xex31d1.htm EX-31.1 11227
6 EX-31.2 snpx-20230331xex31d2.htm EX-31.2 11783
7 EX-32.1 snpx-20230331xex32d1.htm EX-32.1 8468
8 EX-32.2 snpx-20230331xex32d2.htm EX-32.2 8238
  Complete submission text file 0001410578-23-001232.txt   5550560

Data Files

Seq Description Document Type Size
9 EX-101.SCH snpx-20230331.xsd EX-101.SCH 53638
10 EX-101.CAL snpx-20230331_cal.xml EX-101.CAL 26605
11 EX-101.DEF snpx-20230331_def.xml EX-101.DEF 215003
12 EX-101.LAB snpx-20230331_lab.xml EX-101.LAB 398410
13 EX-101.PRE snpx-20230331_pre.xml EX-101.PRE 336729
52 EXTRACTED XBRL INSTANCE DOCUMENT snpx-20230331x10q_htm.xml XML 694728
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Filer) CIK: 0001571934 (see all company filings)

IRS No.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40458 | Film No.: 23923275
SIC: 2834 Pharmaceutical Preparations